Ruxandra Maria Christodorescu

Dr. Ruxandra Maria Christodorescu

University of Medicine and Pharmacy "Victor Babes" Timisoara, Faculty of Medicine, 2 E. Murgu P-ta, 300041 Timisoara, Romania
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in European Heart Journal
Verified
Journal Article
Closed access
CVChristiaan Vrints
Christiaan Vrints
FAFelicita Andreotti
Felicita Andreotti
KKKonstantinos C Koskinas
Konstantinos C Koskinas
XRXavier Rossello
Xavier Rossello
MAMarianna Adamo
Marianna Adamo
ASAleksandr Borisovich Shek
Aleksandr Borisovich Shek

30 August 2024 in European Heart Journal
Verified
Journal Article
Closed access
JMJohn William McEvoy
John William McEvoy
CMCian P McCarthy
Cian P McCarthy
RBRosa Maria Bruno
Rosa Maria Bruno
SBSofie Brouwers
Sofie Brouwers
MCMichelle D Canavan
Michelle D Canavan
GKGulnoz Abdusattarovna Khamidullaeva
Gulnoz Abdusattarovna Khamidullaeva

12 July 2022 in ESC Heart Failure
Verified
Journal Article
Open access
LGLuigina Guasti
Luigina Guasti
PDPolychronis Dilaveris
Polychronis Dilaveris
MMMamas A. Mamas
Mamas A. Mamas
DRDimitrios Richter
Dimitrios Richter
Ruxandra Maria ChristodorescuRuxandra Maria Christodorescu
Ruxandra Maria Christodorescu
MCMartin R. Cowie
Martin R. Cowie
Digital health technology is receiving increasing attention in cardiology. The rise of accessibility of digital health tools including wearable technologies and smart phone applications used in medical practice has created a new era in healthcare. The coronavirus pandemic has provided a new impetus for changes in delivering medical assistance across the world. This Consensus document discusses the potential implementation of digital health technology in older adults, suggesting a practical approach to general cardiologists working in an ambulatory outpatient clinic, highlighting the potential benefit and challenges of digital health in older patients with, or at risk of, cardiovascular disease. Advancing age may lead to a progressive loss of independence, to frailty, and to increasing degrees of disability. In geriatric cardiology, digital health technology may serve as an additional tool both in cardiovascular prevention and treatment that may help by (i) supporting self-caring patients with cardiovascular disease to maintain their independence and improve the management of their cardiovascular disease and (ii) improving the prevention, detection, and management of frailty and supporting collaboration with caregivers. Digital health technology has the potential to be useful for every field of cardiology, but notably in an office-based setting with frequent contact with ambulatory older adults who may be pre-frail or frail but who are still able to live at home. Cardiologists and other healthcare professionals should increase their digital health skills and learn how best to apply and integrate new technologies into daily practice and how to engage older people and their caregivers in a tailored programme of care.

19 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Simona DrãganSimona Drãgan
Simona Drãgan
MSMaria-Corina Serban
Maria-Corina Serban
GDGeorgiana Damian
Georgiana Damian
BFBuleu Florina
Buleu Florina
MVMihaela Valcovici
Mihaela Valcovici
Ruxandra Maria ChristodorescuRuxandra Maria Christodorescu
Ruxandra Maria Christodorescu
Pain is one of the main problems for modern society and medicine, being the most common symptom described by almost all patients. When pain becomes chronic, the life of the patients is dramatically affected, being associated with significant emotional distress and/or functional disability. A complex biopsychosocial evaluation is necessary to better understand chronic pain, where good results can be obtained through interconnected biological, psychological, and social factors. The aim of this study was to find the most relevant articles existent in the PubMed database, one of the most comprehensive databases for medical literature, comprising dietary patterns to alleviate chronic pain. Through a combined search using the keywords “chronic pain” and “diet” limited to the last 10 years we obtained 272 results containing the types of diets used for chronic pain published in the PubMed database. Besides classical and alternative methods of treatment described in literature, it was observed that different diets are also a valid solution, due to many components with antioxidant and anti-inflammatory qualities capable to influence chronic pain and to improve the quality of life. Thirty-eight clinical studies and randomized controlled trials are analyzed, in an attempt to characterize present-day dietary patterns and interventions to alleviate chronic pain.

23 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
ABAlina Diduta Brie
Alina Diduta Brie
Ruxandra Maria ChristodorescuRuxandra Maria Christodorescu
Ruxandra Maria Christodorescu
Roxana PopescuRoxana Popescu
Roxana Popescu
OAOvidiu Adam
Ovidiu Adam
ATAlexandru Tirziu
Alexandru Tirziu
DBDaniel Miron Brie
Daniel Miron Brie
Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, especially in regions like Eastern Europe, South Asia, and Latin America. A significant portion of these cases (80%) is linked to atherosclerosis, which can lead to severe conditions like ischemic heart disease and stroke, with atherosclerosis (ATS) responsible for the majority of cases. This review explores the multifaceted relationship between insulin resistance (IR) and ATS, highlighting their roles as both independent and interrelated contributors to cardiovascular risk. ATS is characterized by lipid accumulation and chronic inflammation within arterial walls, driven by factors such as hypertension, dyslipidemia, and genetic predisposition, with endothelial dysfunction as a key early event. The early detection of subclinical ATS is critical and can be achieved through a combination of non-invasive imaging techniques—such as coronary artery calcium scoring and carotid ultrasound—and comprehensive risk profiling. IR, marked by impaired glucose uptake in liver, muscle, and adipose tissue, often precedes early diabetes and is associated with metabolic disturbances, including dyslipidemia and chronic inflammation. The diagnosis of IR relies on surrogate indices such as HOMA-IR, the QUICKI, and the TyG index, which facilitate screening in clinical practice. Compelling evidence indicates that IR independently predicts the progression of atherosclerotic plaques, even in non-diabetic individuals, and operates through both traditional risk factors and direct vascular effects. Understanding and targeting the IR–ATS axis is essential for the effective prevention and management of cardiovascular disease.

25 June 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
DRDimitrios Richter
Dimitrios Richter
LGLuigina Guasti
Luigina Guasti
FKFriedrich Koehler
Friedrich Koehler
ASAlessandro Squizzato
Alessandro Squizzato
SNStefano Nistri
Stefano Nistri
MFMarc Ferrini
Marc Ferrini
Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID-19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID-19 and about the appropriate approach to these patients. Heart failure, type 1 and type 2 myocardial infarction, arrhythmias, myocarditis, pulmonary fibrosis, and thrombosis have been shown to be related to severe acute respiratory syndrome coronavirus 2 infection, and a ‘long COVID-19’ illness has been recognized with fatigue, chest pain, and dyspnoea among the most frequent symptoms reported after discharge from hospital. This paper focuses on some open questions that cardiologists are going to face during the next months in a general cardiology outpatient clinic, in particular how to evaluate a ‘post-COVID’ patient during follow-up of CV complications of the acute phase and how to manage new CV symptoms that could be the consequence, at least in part, of heart/vessels and/or lung involvement of the previous virus infection. Present symptoms and signs, history of previous CV disease (both preceding COVID-19 and occurring during viral infection), and specific laboratory and imaging measurements during the acute phase may be of interest in focusing on how to approach the clinical evaluation of a post-COVID patient and how to integrate in our standard of care the new information on COVID-19, possibly in a multidisciplinary view. Dealing with the increased COVID-associated CV risk burden and becoming acquainted with potential new e-cardiology approaches aimed at integrating the cardiology practice are relevant new challenges brought by severe acute respiratory syndrome coronavirus 2 infection and its sequelae.